
### [NCIT:C6339](http://purl.obolibrary.org/obo/NCIT_C6339)
**Label:** Uterine Corpus Sarcoma

**Subclasses:** [NCIT:C8258](http://purl.obolibrary.org/obo/NCIT_C8258) (Stage I Uterine Sarcoma AJCC v7), [NCIT:C8259](http://purl.obolibrary.org/obo/NCIT_C8259) (Stage II Uterine Sarcoma AJCC v7), [NCIT:C8972](http://purl.obolibrary.org/obo/NCIT_C8972) (Uterine Corpus Undifferentiated Sarcoma), [NCIT:C40219](http://purl.obolibrary.org/obo/NCIT_C40219) (Uterine Corpus Endometrial Stromal Sarcoma), [NCIT:C9179](http://purl.obolibrary.org/obo/NCIT_C9179) (Stage IV Uterine Sarcoma AJCC v7), [NCIT:C6340](http://purl.obolibrary.org/obo/NCIT_C6340) (Uterine Corpus Leiomyosarcoma), [NCIT:C40223](http://purl.obolibrary.org/obo/NCIT_C40223) (Uterine Corpus Low Grade Endometrial Stromal Sarcoma), [NCIT:C8261](http://purl.obolibrary.org/obo/NCIT_C8261) (Recurrent Uterine Corpus Sarcoma), [NCIT:C126998](http://purl.obolibrary.org/obo/NCIT_C126998) (Uterine Corpus High Grade Endometrial Stromal Sarcoma), [NCIT:C8260](http://purl.obolibrary.org/obo/NCIT_C8260) (Stage III Uterine Sarcoma AJCC v7), [NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma), [NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma), [NCIT:C136708](http://purl.obolibrary.org/obo/NCIT_C136708) (Uterine Corpus Sarcoma by AJCC v7 Stage), [NCIT:C127058](http://purl.obolibrary.org/obo/NCIT_C127058) (Uterine Corpus Rhabdomyosarcoma), 

**Class expressions from DL-Learner:**

- [UBERON:0009853](http://purl.obolibrary.org/obo/UBERON_0009853) (body of uterus) 54.17%
- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 54.17%
- Thing 52.77%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 39.96%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36657](http://purl.obolibrary.org/obo/NCIT_C36657) (Polysomy 17))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36656](http://purl.obolibrary.org/obo/NCIT_C36656) (Polysomy 10))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36655](http://purl.obolibrary.org/obo/NCIT_C36655) (Polysomy 3))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36654](http://purl.obolibrary.org/obo/NCIT_C36654) (CDH1 Gene Inactivation))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36652](http://purl.obolibrary.org/obo/NCIT_C36652) (CCND1 Gene Amplification))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36651](http://purl.obolibrary.org/obo/NCIT_C36651) (FGFR2 Gene Amplification))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36650](http://purl.obolibrary.org/obo/NCIT_C36650) (FGFR1 Gene Amplification))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36649](http://purl.obolibrary.org/obo/NCIT_C36649) (EGFR Gene Amplification))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36648](http://purl.obolibrary.org/obo/NCIT_C36648) (der(1;16)(q10;p10)))) 39.52%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C36647](http://purl.obolibrary.org/obo/NCIT_C36647) (i(1)(q10)))) 39.52%


